DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS




 Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb
Employees:
Symbol: BMY
 





Collaborations

Gilead 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys, Inc.  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech, Inc.  - Cancer

Gilead (Seattle, WA) 





 Company News
Bristol-Myers Squibb (BMY) Release: Study Of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results In Preventing Viral Replication Via Different Mechanism Of Action Than Current Therapies 2/26/2015 11:17:38 AM
Regen BioPharma Comments On Dcellvax Cancer IDO-Targeting Technology In Relation To Bristol-Myers Squibb (BMY)-Flexus Biosciences Announcement 2/25/2015 1:54:57 PM
Bristol-Myers Squibb (BMY) Release: 48-Week Analysis Of Investigational HIV-1 Attachment Inhibitor Paves Way For Phase III Trial Initiation 2/25/2015 10:40:35 AM
Jacobs Awarded Contract From Bristol-Myers Squibb (BMY) 2/24/2015 12:28:39 PM
Bristol-Myers Squibb (BMY)To Present At Cowen and Company Annual Global Health Care Conference 2/24/2015 11:17:22 AM
Bristol-Myers Squibb Foundation Awards GRU Cancer Center Three-Year, $1.74M Grant To Address Lung Cancer Among Neediest Communities In Central Savannah River Area 2/23/2015 10:30:04 AM
Bristol-Myers Squibb (BMY) Snaps Up Private Cancer Drugmaker in $1.25 Billion Buyout 2/23/2015 6:57:05 AM
Rigel (RIGL) Lands $339 Million+ Cancer Deal With Bristol-Myers Squibb (BMY) 2/23/2015 6:38:33 AM
Best Hair in Biopharma Race Heats Up As Bristol-Myers Squibb (BMY) Elicker Pulls Ahead 2/19/2015 11:23:04 AM
FDA Approves Bristol-Myers Squibb Company (BMY)’s Evotaz™ (Atazanavir And Cobicistat) For The Treatment Of HIV-1 Infection In Adults 1/30/2015 6:06:45 AM
12345678910...